The new Austrian/German/Swiss guidelines for trans health care for minors have been published. Overall, they look pretty good, though I think there are a few places where they could be improved. That said, they form a strong counterpoint to Cass etc. https://t.co/7S2WNsJIZe
@KateyDotDev @transscribe Except that most of the legislation wasn't about elite sports, but school sports, some even banning the use of public facilities for trans-inclusive clubs. And trust me, it's not about fairness, but about them finding us icky. https://t.co/SDdmkR3FDx
I have a story to share here. I was a gymnast as a teen. A trans female gymnast, to be precise. That was in the early 2010s in SoCal. My parents and I had done all to avoid courting controversy, as we already had enough to deal with. (1/5)
@BevJacksonAuth@speakoutsister As we're not looking at the general population, but at (potentially) intersex athletes, testing for Y chromosomes doesn't tell you anything and your math is completely off (please understand conditional probabilities). See e.g. the case of Ewa Kłobukowska. https://t.co/4LcYcxHH5F
Regardless, even if the claims in the study were fully accurate, then it would (1) be likely incompatible with the claims that 100% kids on puberty blockers go on to CSH and (2) would strengthen the case for puberty blockers for diagnostic purposes. (25/25)
I have a number of issues with Moti Gorin's response, which I will explain subsequently. I am glad, however, that he at least agrees that it is the balance of beneficence and non-maleficence that matters, not a simplistic "first, do no harm". (1/25)
If authors pretty much openly out themselves as ideologues, concerns about bias are justified, especially when the data being offered is pretty sparse. (24/25)